Sanyou Biopharmaceuticals Co., Ltd.

Industry

  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
  • In Vitro Diagnostics
  • Contract Research Organization-CRO
  • Research, Analytical Equipment & Supplies
See more in Biomedtracker

Latest on Sanyou Biopharmaceuticals Co., Ltd.

Scrip

Asia Deal Watch: Nippon Shinyaku Takes On Intractable Rare Disease With MiNA

 
• By Joseph Haas, Dexter Jie Yan, Vibha Ravi, Lisa Takagi, and Anju Ghangurde

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. MiNA Will Provide RNAa Candidates

Scrip

Deal Watch: Gilead Acquires Xilio’s IL-12 Activating Candidate

 
• By Joseph Haas and Alaric DeArment

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Gilead Gets Xilio’s Phase I Cancer Drug

Scrip

Deal Watch: Takeda Calls Upon The UK’s F-star Again For Bispecific Candidates

 
• By Joseph Haas and Lisa Takagi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Takeda, F-star Sign Joint Research Pact

Scrip

Deal Watch: Roche, PhoreMost Enter Into Multi-Target Collaboration

 
• By Joseph Haas and Mandy Jackson

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. PhoreMost To Deploy SITESEEKER Platform